ISO: The Newest SIBO Variant Nobody Is Talking About

If you have been investigating SIBO for any length of time, you have probably encountered hydrogen SIBO and methane SIBO (now technically classified as intestinal methanogen overgrowth, or IMO). But there is a third distinct type of intestinal gas dysbiosis that receives far less attention despite affecting a meaningful subset of patients who have been struggling for answers — Intestinal Sulfide Overproduction, or ISO. Described and defined by Dr. Mark Pimentel and his team at Cedars-Sinai, ISO is not simply a variation of hydrogen SIBO. It has a distinct microbiology, distinct symptoms, and requires a distinct treatment approach. Here is what you need to know.

Pimentel's Classification System: Three Types of Gas Dysbiosis

Dr. Mark Pimentel, one of the leading SIBO researchers in the world, has proposed a classification system that organizes intestinal gas disorders by the primary gas produced by the overgrown microorganisms: Hydrogen SIBO (now often called SIBO-H) involves overgrowth of hydrogen-producing bacteria in the small intestine — typically gram-negative facultative anaerobes like E. coli, Klebsiella, and related species. These organisms ferment carbohydrates and produce hydrogen gas, causing classic SIBO symptoms: bloating, distension, diarrhea, and abdominal cramping that worsen with carbohydrate intake. Hydrogen SIBO is diagnosed by elevated breath hydrogen on lactulose or glucose breath testing. Intestinal Methanogen Overgrowth (IMO, formerly methane SIBO) involves overgrowth of methane-producing archaea — primarily Methanobrevibacter smithii — that produce methane by consuming hydrogen. High methane is associated with constipation, slower transit, and distinct metabolic effects. It is diagnosed by elevated breath methane. ISO — Intestinal Sulfide Overproduction — is the third category, and it represents overgrowth of sulfur-reducing bacteria that produce hydrogen sulfide (H2S) rather than hydrogen or methane as their primary fermentation byproduct. H2S is a toxic gas at high concentrations, highly reactive with the gut lining, and associated with a distinct symptom pattern and clinical presentation that sets it apart from the other two types.

Sulfur-Reducing Bacteria: The Microbiology of ISO

The organisms responsible for ISO are sulfur-reducing bacteria (SRB) — a diverse group of anaerobes that use sulfate, sulfite, and other sulfur compounds as electron acceptors in their metabolism, producing H2S as a byproduct. The major SRB implicated in human gut ISO include Desulfovibrio species (particularly D. vulgaris, D. desulfuricans, and D. piger), Bilophila wadsworthia, and certain Fusobacterium species. Desulfovibrio species are the most studied in the context of human gut H2S production. They are normally present in low abundances in the healthy colon but can overgrow in conditions of high sulfur substrate availability — either from dietary sulfur (meat, eggs, dairy, cruciferous vegetables, onions, garlic, wine) or from mucin sulfation in the gut lining. Bilophila wadsworthia is particularly interesting because it thrives on taurine-conjugated bile acids, which are produced in higher quantities on high-fat diets — offering a mechanistic explanation for why high-fat diets may worsen ISO symptoms in some individuals. Unlike the organisms in hydrogen SIBO, which primarily overgrow in the small intestine, SRB can be problematic throughout the colon — making the classification of ISO as SIBO technically imprecise. Some researchers prefer the term "intestinal sulfide overproduction" precisely because the problem is not necessarily limited to the small intestine. The issue is overproduction of H2S at any gut location, rather than strictly bacterial overgrowth in the small bowel.

Symptoms Unique to ISO: How to Recognize It

ISO has a symptom profile that overlaps with other SIBO types in some ways — bloating, abdominal discomfort, altered stool pattern — but includes several distinctive features that can help differentiate it. Sulfur-smelling burps and flatulence are the most distinctive symptom. If your gas smells like rotten eggs or sulfur, and this is a consistent pattern rather than an occasional occurrence, ISO is high on the differential. This is qualitatively different from the less-specific gas odor patterns seen in hydrogen or methane SIBO. Diarrhea and loose stools are more common in ISO than constipation. H2S has direct secretagogue effects on the colon — it stimulates fluid secretion — and also impairs colonocyte energy metabolism, reducing the colon's ability to absorb water effectively. This creates a diarrhea-predominant pattern that often leads to misdiagnosis as IBS-D (irritable bowel syndrome with diarrhea). Bladder symptoms — urinary urgency, frequency, pain, and interstitial cystitis-like presentations — are associated with elevated H2S in a subset of ISO patients. The mechanism likely involves systemic H2S absorption and its effect on the bladder epithelium, which shares tissue characteristics with the gut mucosa. This bladder-gut connection has been noted by multiple clinicians treating ISO patients and is not seen with hydrogen or methane dysbiosis. Fatigue, brain fog, and a general sense of unwellness that is disproportionate to GI symptoms can also be features of ISO, potentially reflecting systemic H2S effects on mitochondrial function.

The Trio-Smart Test: How ISO Is Diagnosed

Standard two-gas breath testing measures hydrogen and methane. Because ISO primarily involves H2S rather than H2 or CH4, standard breath tests frequently come back flat or equivocal for patients who actually have ISO — leading to years of missed diagnosis and inappropriate treatment. The Trio-Smart breath test, developed by Gemelli Biotech and associated with the Pimentel research group at Cedars-Sinai, measures all three gases: hydrogen, methane, and hydrogen sulfide. It uses lactulose as the substrate (a non-absorbable sugar that reaches the colon and provokes fermentation) and captures exhaled breath samples at multiple time points after ingestion. A 2022 study published in the American Journal of Gastroenterology validated the Trio-Smart test, demonstrating that H2S measurement added clinically significant diagnostic information beyond hydrogen and methane testing alone, identifying a population of patients with gas-related gut symptoms who had flat or normal conventional breath tests but elevated H2S. This paper established ISO as a formally recognized clinical entity with validated diagnostic criteria. The Trio-Smart test is available by mail-order in the United States and can be ordered by a physician or through direct-to-consumer channels in some states. Interpretation requires clinician guidance, as the clinical cutoffs for H2S are still being refined as research continues.

Treatment Differences From Other SIBO Types

Because ISO involves different organisms than hydrogen or methane SIBO, it responds differently to standard antibiotic protocols. Rifaximin, the go-to for hydrogen SIBO, has limited activity against Desulfovibrio species and other SRB. It may provide some benefit — particularly if there is co-existing hydrogen overgrowth — but is generally not sufficient as monotherapy for ISO. Metronidazole and tinidazole, which are active against many anaerobic species including Desulfovibrio, are more appropriate antibiotic choices for ISO. Some practitioners have also used bismuth subsalicylate (Pepto-Bismol), which has direct H2S-binding properties — bismuth binds sulfide and reduces its luminal concentration — as both a symptomatic treatment and a microbiome modifier. Molybdenum supplementation has been explored as a cofactor that affects sulfur metabolism, though clinical evidence is limited. More consistently useful is bismuth, which is available over the counter and has a well-established H2S-reducing mechanism. Herbal antimicrobials with activity against sulfur-reducing bacteria include oregano oil, berberine, and allicin (garlic-derived compounds, though high-allicin garlic can paradoxically worsen symptoms for some ISO patients by providing additional sulfur substrate). Protocol selection for herbal treatment of ISO should be guided by a knowledgeable practitioner given the complexity.

The Low-Sulfur Diet: Dietary Considerations in ISO

Diet plays a particularly important and specific role in ISO management. Because SRB use sulfur compounds as their metabolic substrate, reducing dietary sulfur intake starves the responsible organisms and reduces H2S production. The low-sulfur diet for ISO involves reducing high-sulfur foods: meat (especially red meat and eggs, which are high in sulfur-containing amino acids cysteine and methionine), dairy products, cruciferous vegetables (broccoli, cabbage, cauliflower, Brussels sprouts), alliums (garlic, onions, leeks), sulfur-preserved foods and wines, and dried fruits preserved with sulfites. This is meaningfully different from the Low FODMAP diet used for hydrogen SIBO — some low-FODMAP foods are high in sulfur (garlic, for instance, is simultaneously high-FODMAP and high-sulfur), and some high-FODMAP foods (like certain fruits) are low in sulfur. It is worth noting that the low-sulfur diet is meant to be therapeutic, not permanent. Cruciferous vegetables and alliums are enormously health-promoting for the broader microbiome and for general health. Once H2S overproduction is under control, gradual reintroduction of these foods is the goal. Tracking which specific foods trigger sulfur symptoms — using a detailed food and symptom diary through a tool like GLP1Gut — is the most precise way to identify your personal sulfur threshold and guide a systematic reintroduction process.

**Disclaimer:** This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting any new treatment or making changes to your existing treatment plan.